Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease

• DNA damage biomarkers in blood, buccal and brain tissue associated with MCI and AD.
• Evidence and knowledge gaps of blood micronutrients associated with MCI and AD.
• Biological plausibility and association of these novel biomarkers with MCI and AD.
• Potential use of nutritional and genomic biomarkers to identify increased risk.